What is another name for the medication Mobidin (magnesium salicylate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mobidin is Magnesium Salicylate

Mobidin is the brand name for magnesium salicylate, a non-steroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. This medication should not be confused with Mobic (meloxicam), which is a completely different NSAID 1.

Key Distinguishing Features

Magnesium salicylate (Mobidin) is a salicylate compound that:

  • Contains magnesium bound to salicylic acid
  • Exists as magnesium salicylate tetrahydrate in its crystalline form 2
  • Functions similarly to aspirin but with different pharmacokinetic properties
  • Shows comparable plasma salicylate levels to aspirin when administered in equivalent doses 3

Critical Clinical Distinction

Do not confuse Mobidin with Mobic - these are entirely different medications:

  • Mobic (meloxicam) is indicated for osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis 1
  • Mobidin (magnesium salicylate) is a salicylate NSAID with different indications and properties

Pharmacological Properties

Magnesium salicylate demonstrates:

  • Rapid dissolution with a half-life of approximately 12 minutes in optimally formulated tablets 2
  • Bioequivalent absorption to aspirin, with 60-68% of the dose excreted as salicylurate in urine 3
  • No significant differences in rate and extent of salicylate absorption compared to aspirin or choline magnesium trisalicylate 3

Important Safety Consideration

As a salicylate, Mobidin carries the same risks as other salicylate-containing medications, including potential for salicylate toxicity requiring extracorporeal treatment (hemodialysis) at concentrations >7.2 mmol/L (100 mg/dL) in acute poisoning 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.